Logo image of LXU

LSB INDUSTRIES INC (LXU) Stock Fundamental Analysis

USA - New York Stock Exchange - NYSE:LXU - US5021601043 - Common Stock

9.825 USD
-0.14 (-1.36%)
Last: 1/22/2026, 3:41:46 PM
Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to LXU. LXU was compared to 82 industry peers in the Chemicals industry. Both the profitability and the financial health of LXU get a neutral evaluation. Nothing too spectacular is happening here. While showing a medium growth rate, LXU is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

  • LXU had positive earnings in the past year.
  • In the past year LXU had a positive cash flow from operations.
  • In multiple years LXU reported negative net income over the last 5 years.
  • LXU had a positive operating cash flow in 4 of the past 5 years.
LXU Yearly Net Income VS EBIT VS OCF VS FCFLXU Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M -200M 300M

1.2 Ratios

  • LXU's Return On Assets of -0.06% is in line compared to the rest of the industry. LXU outperforms 52.44% of its industry peers.
  • With a Return On Equity value of -0.13%, LXU perfoms like the industry average, outperforming 52.44% of the companies in the same industry.
  • The Return On Invested Capital of LXU (2.77%) is comparable to the rest of the industry.
  • Measured over the past 3 years, the Average Return On Invested Capital for LXU is in line with the industry average of 6.11%.
  • The last Return On Invested Capital (2.77%) for LXU is well below the 3 year average (7.85%), which needs to be investigated, but indicates that LXU had better years and this may not be a problem.
Industry RankSector Rank
ROA -0.06%
ROE -0.13%
ROIC 2.77%
ROA(3y)5.51%
ROA(5y)-2.47%
ROE(3y)15.37%
ROE(5y)-5.05%
ROIC(3y)7.85%
ROIC(5y)N/A
LXU Yearly ROA, ROE, ROICLXU Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40

1.3 Margins

  • With a Operating Margin value of 6.06%, LXU perfoms like the industry average, outperforming 45.12% of the companies in the same industry.
  • In the last couple of years the Operating Margin of LXU has declined.
  • LXU has a worse Gross Margin (12.46%) than 78.05% of its industry peers.
  • In the last couple of years the Gross Margin of LXU has grown nicely.
Industry RankSector Rank
OM 6.06%
PM (TTM) N/A
GM 12.46%
OM growth 3Y-59.74%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-28.46%
GM growth 5Y46.21%
LXU Yearly Profit, Operating, Gross MarginsLXU Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20

More info and screens

5

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so LXU is destroying value.
  • Compared to 1 year ago, LXU has less shares outstanding
  • LXU has more shares outstanding than it did 5 years ago.
  • LXU has a better debt/assets ratio than last year.
LXU Yearly Shares OutstandingLXU Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
LXU Yearly Total Debt VS Total AssetsLXU Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B

2.2 Solvency

  • LXU has an Altman-Z score of 1.72. This is a bad value and indicates that LXU is not financially healthy and even has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of 1.72, LXU is in line with its industry, outperforming 43.90% of the companies in the same industry.
  • A Debt/Equity ratio of 0.89 indicates that LXU is somewhat dependend on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 0.89, LXU is doing worse than 62.20% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.89
Debt/FCF N/A
Altman-Z 1.72
ROIC/WACC0.25
WACC11.25%
LXU Yearly LT Debt VS Equity VS FCFLXU Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M 600M

2.3 Liquidity

  • LXU has a Current Ratio of 2.84. This indicates that LXU is financially healthy and has no problem in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 2.84, LXU belongs to the top of the industry, outperforming 80.49% of the companies in the same industry.
  • A Quick Ratio of 2.28 indicates that LXU has no problem at all paying its short term obligations.
  • With an excellent Quick ratio value of 2.28, LXU belongs to the best of the industry, outperforming 84.15% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.84
Quick Ratio 2.28
LXU Yearly Current Assets VS Current LiabilitesLXU Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

More info and screens

4

3. Growth

3.1 Past

  • LXU shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 40.00%, which is quite impressive.
  • The Revenue has grown by 12.49% in the past year. This is quite good.
  • Measured over the past years, LXU shows a small growth in Revenue. The Revenue has been growing by 7.43% on average per year.
EPS 1Y (TTM)40%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%127.73%
Revenue 1Y (TTM)12.49%
Revenue growth 3Y-2.07%
Revenue growth 5Y7.43%
Sales Q2Q%42.31%

3.2 Future

  • The Earnings Per Share is expected to grow by 1.25% on average over the next years.
  • Based on estimates for the next years, LXU will show a small growth in Revenue. The Revenue will grow by 3.57% on average per year.
EPS Next Y-26.05%
EPS Next 2Y-11.94%
EPS Next 3Y1.51%
EPS Next 5Y1.25%
Revenue Next Year18.61%
Revenue Next 2Y9.4%
Revenue Next 3Y6.98%
Revenue Next 5Y3.57%

3.3 Evolution

  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
LXU Yearly Revenue VS EstimatesLXU Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 200M 400M 600M 800M
LXU Yearly EPS VS EstimatesLXU Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 2 -2

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 20.05, LXU is valued on the expensive side.
  • LXU's Price/Earnings is on the same level as the industry average.
  • LXU is valuated rather cheaply when we compare the Price/Earnings ratio to 27.32, which is the current average of the S&P500 Index.
  • The Price/Forward Earnings ratio is 22.62, which indicates a rather expensive current valuation of LXU.
  • LXU's Price/Forward Earnings is on the same level as the industry average.
  • LXU is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 24.30, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 20.05
Fwd PE 22.62
LXU Price Earnings VS Forward Price EarningsLXU Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • LXU's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. LXU is cheaper than 79.27% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 7.58
LXU Per share dataLXU EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-11.94%
EPS Next 3Y1.51%

More info and screens

0

5. Dividend

5.1 Amount

  • No dividends for LXU!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

LSB INDUSTRIES INC

NYSE:LXU (1/22/2026, 3:41:46 PM)

9.825

-0.14 (-1.36%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)10-29
Earnings (Next)02-24
Inst Owners59.7%
Inst Owner Change0.05%
Ins Owners4.15%
Ins Owner Change-0.34%
Market Cap706.81M
Revenue(TTM)585.07M
Net Income(TTM)-668.00K
Analysts75
Price Target10.14 (3.21%)
Short Float %2.89%
Short Ratio3.37
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)0.51%
Min EPS beat(2)-33.99%
Max EPS beat(2)35.01%
EPS beat(4)3
Avg EPS beat(4)51.48%
Min EPS beat(4)-33.99%
Max EPS beat(4)135.15%
EPS beat(8)6
Avg EPS beat(8)53.34%
EPS beat(12)8
Avg EPS beat(12)28.4%
EPS beat(16)10
Avg EPS beat(16)40.69%
Revenue beat(2)1
Avg Revenue beat(2)5.1%
Min Revenue beat(2)-4.79%
Max Revenue beat(2)14.99%
Revenue beat(4)3
Avg Revenue beat(4)7.5%
Min Revenue beat(4)-4.79%
Max Revenue beat(4)14.99%
Revenue beat(8)6
Avg Revenue beat(8)5.82%
Revenue beat(12)9
Avg Revenue beat(12)3.98%
Revenue beat(16)12
Avg Revenue beat(16)4.06%
PT rev (1m)0.63%
PT rev (3m)12.77%
EPS NQ rev (1m)11.43%
EPS NQ rev (3m)39.29%
EPS NY rev (1m)20.59%
EPS NY rev (3m)5.13%
Revenue NQ rev (1m)3.1%
Revenue NQ rev (3m)4.6%
Revenue NY rev (1m)-0.97%
Revenue NY rev (3m)3.09%
Valuation
Industry RankSector Rank
PE 20.05
Fwd PE 22.62
P/S 1.21
P/FCF N/A
P/OCF 8.67
P/B 1.4
P/tB 1.4
EV/EBITDA 7.58
EPS(TTM)0.49
EY4.99%
EPS(NY)0.43
Fwd EY4.42%
FCF(TTM)-0.04
FCFYN/A
OCF(TTM)1.13
OCFY11.54%
SpS8.13
BVpS7.01
TBVpS7
PEG (NY)N/A
PEG (5Y)N/A
Graham Number8.79
Profitability
Industry RankSector Rank
ROA -0.06%
ROE -0.13%
ROCE 3.36%
ROIC 2.77%
ROICexc 3.23%
ROICexgc 3.23%
OM 6.06%
PM (TTM) N/A
GM 12.46%
FCFM N/A
ROA(3y)5.51%
ROA(5y)-2.47%
ROE(3y)15.37%
ROE(5y)-5.05%
ROIC(3y)7.85%
ROIC(5y)N/A
ROICexc(3y)11.08%
ROICexc(5y)N/A
ROICexgc(3y)11.1%
ROICexgc(5y)N/A
ROCE(3y)9.64%
ROCE(5y)N/A
ROICexgc growth 3Y-59.46%
ROICexgc growth 5YN/A
ROICexc growth 3Y-59.42%
ROICexc growth 5YN/A
OM growth 3Y-59.74%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-28.46%
GM growth 5Y46.21%
F-Score7
Asset Turnover0.51
Health
Industry RankSector Rank
Debt/Equity 0.89
Debt/FCF N/A
Debt/EBITDA 3.83
Cap/Depr 103.35%
Cap/Sales 14.45%
Interest Coverage 1.15
Cash Conversion 69.57%
Profit Quality N/A
Current Ratio 2.84
Quick Ratio 2.28
Altman-Z 1.72
F-Score7
WACC11.25%
ROIC/WACC0.25
Cap/Depr(3y)96.58%
Cap/Depr(5y)76.59%
Cap/Sales(3y)11.38%
Cap/Sales(5y)9.83%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)40%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%127.73%
EPS Next Y-26.05%
EPS Next 2Y-11.94%
EPS Next 3Y1.51%
EPS Next 5Y1.25%
Revenue 1Y (TTM)12.49%
Revenue growth 3Y-2.07%
Revenue growth 5Y7.43%
Sales Q2Q%42.31%
Revenue Next Year18.61%
Revenue Next 2Y9.4%
Revenue Next 3Y6.98%
Revenue Next 5Y3.57%
EBIT growth 1Y258.45%
EBIT growth 3Y-60.57%
EBIT growth 5YN/A
EBIT Next Year2325.63%
EBIT Next 3Y195.69%
EBIT Next 5Y92.24%
FCF growth 1Y-101.95%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-60.6%
OCF growth 3Y-0.4%
OCF growth 5Y110.4%

LSB INDUSTRIES INC / LXU FAQ

What is the fundamental rating for LXU stock?

ChartMill assigns a fundamental rating of 4 / 10 to LXU.


What is the valuation status for LXU stock?

ChartMill assigns a valuation rating of 2 / 10 to LSB INDUSTRIES INC (LXU). This can be considered as Overvalued.


What is the profitability of LXU stock?

LSB INDUSTRIES INC (LXU) has a profitability rating of 4 / 10.


What are the PE and PB ratios of LSB INDUSTRIES INC (LXU) stock?

The Price/Earnings (PE) ratio for LSB INDUSTRIES INC (LXU) is 20.05 and the Price/Book (PB) ratio is 1.4.


Can you provide the dividend sustainability for LXU stock?

The dividend rating of LSB INDUSTRIES INC (LXU) is 0 / 10 and the dividend payout ratio is 0%.